Donald Anthony St Claire, MD
Interventional Cardiology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 5 carriers
- Offices
- 9
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Claire’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G68721 · Current
Licensed to practise in California · since 1990 · expires 2027-11-30 · Hahnemann University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$735,755
Medicare paid this office $735,755 for 1,813 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 408 | $120,252 | $163 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 78 | $119,483 | $1,512 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 423 | $90,426 | $186 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 78 | $64,809 | $410 |
| Ultrasound of both sides of head and neck blood flow | 333 | $62,622 | $187 |
See all 47 services
| Long return visit (40+ min) | 408 | $120,252 | $163 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 78 | $119,483 | $1,512 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 423 | $90,426 | $186 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 78 | $64,809 | $410 |
| Ultrasound of both sides of head and neck blood flow | 333 | $62,622 | $187 |
| Return visit (30+ min) | 408 | $57,721 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $19,363 | $104 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 71 | $15,786 | $222 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 732 | $14,763 | $12 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 555 | $10,810 | $15 |
| New patient visit (60+ min) | 52 | $10,578 | $203 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 50 | $9,738 | $195 |
| Interpretation and report of ultrasound of heart | 118 | $9,183 | $75 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $8,652 | $455 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $8,596 | $452 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $8,221 | $149 |
| Replacement of aortic valve through the skin and femoral artery | 13 | $7,894 | $607 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $7,309 | $79 |
| Programming of dual lead pacemaker system | 50 | $6,951 | $74 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 91 | $6,350 | $68 |
| New patient visit (45+ min) | 34 | $5,079 | $149 |
| 3d radiographic procedure | 176 | $5,044 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 68 | $4,568 | $61 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,661 | $282 |
| External shock to heart to regulate heart beat | 31 | $3,486 | $97 |
| Short return visit (20+ min) | 39 | $3,139 | $78 |
| Ultrasound of heart with probe in esophagus, with report | 32 | $3,088 | $94 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 18 | $2,896 | $76 |
| Heart muscle strain imaging | 58 | $2,548 | $39 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $2,480 | $155 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 102 | $2,331 | $22 |
| Injection, regadenoson, 0.1 mg | 81 | $2,288 | None |
| Long return visit (40+ min) | 16 | $2,201 | $129 |
| Ultrasound of heart blood flow, valves and chambers | 134 | $2,194 | $16 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 24 | $1,429 | $60 |
| Heart rhythm recording of continous external ekg over 8-15 days | 101 | $1,267 | $12 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,252 | $78 |
| Return visit (30+ min) | 14 | $1,223 | $87 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $1,155 | $44 |
| Ultrasound of heart, follow-up | 38 | $923 | $22 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 41 | $911 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 74 | $782 | $10 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 40 | $531 | $12 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 12 | $521 | $43 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 147 | $423 | $3 |
| Ultrasonic guidance for blood vessel access | 18 | $225 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $100 | $6 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 37 | More than 72% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,813 Original Medicare patients in 2024. Average age 79 · Under 65 1% · 85 and older 24% · Women 44% · Also on Medicaid 3% · Health risk score 1.18. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 51% · Atrial fibrillation 50% · Heart failure 24% · Chronic kidney disease 23% · Diabetes 22% · Cancer 19% · COPD 12% · Depression 11% · Stroke 9% · Dementia 6%.
The office billed $3,454,411, Medicare allowed $954,486 and paid $735,755; for 7,011 services of 85 kinds; $2,288 of it was for drugs given in the office and $733,466 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,813 | 7,011 | 79 | 1.18 | $3,454,411 | $735,755 |
| 2023 | 1,823 | 6,434 | 79 | 1.20 | $3,430,207 | $778,400 |
| 2022 | 1,479 | 5,386 | 78 | 1.21 | $2,698,516 | $651,367 |
| 2021 | 1,194 | 5,657 | 78 | 1.16 | $3,002,204 | $757,678 |
| 2020 | 940 | 5,653 | 78 | 1.45 | $2,365,746 | $596,891 |
| 2019 | 1,075 | 6,544 | 78 | 1.36 | $2,778,071 | $659,326 |
| 2018 | 1,100 | 6,559 | 78 | 1.41 | $2,609,967 | $633,750 |
| 2017 | 1,142 | 6,198 | 77 | 1.33 | $2,580,176 | $622,223 |
| 2016 | 1,125 | 5,812 | 78 | 1.35 | $2,376,006 | $572,978 |
| 2015 | 1,097 | 6,204 | 78 | 1.45 | $2,485,974 | $652,033 |
| 2014 | 1,051 | 5,806 | 78 | 1.36 | $2,367,697 | $662,013 |
| 2013 | 1,053 | 5,853 | 78 | 1.39 | $2,337,941 | $606,433 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 44 services
| Long return visit (40+ min) | 463 | $135,010 | $161 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 77 | $120,727 | $1,548 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 444 | $93,553 | $186 |
| Ultrasound of both sides of head and neck blood flow | 398 | $78,289 | $194 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 77 | $65,115 | $417 |
| Return visit (30+ min) | 343 | $46,824 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 117 | $29,056 | $106 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 91 | $20,599 | $224 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 764 | $14,932 | $13 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $14,563 | $441 |
| Injection, regadenoson, 0.1 mg | 85 | $14,331 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 63 | $12,367 | $193 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $9,079 | $149 |
| Programming of dual lead pacemaker system | 57 | $8,455 | $75 |
| New patient visit (60+ min) | 41 | $8,347 | $204 |
| Replacement of aortic valve through the skin and femoral artery | 13 | $8,230 | $633 |
| Ultrasound of heart with probe in esophagus, with report | 70 | $6,640 | $94 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 13 | $5,976 | $460 |
| Interpretation and report of ultrasound of heart | 68 | $5,375 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | $4,576 | $62 |
| New patient visit (45+ min) | 29 | $4,405 | $152 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 62 | $4,277 | $68 |
| 3d radiographic procedure | 144 | $4,019 | $25 |
| External shock to heart to regulate heart beat | 32 | $3,358 | $93 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 20 | $3,329 | $166 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 20 | $3,049 | $76 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 99 | $2,447 | $23 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 25 | $2,168 | $80 |
| Short return visit (20+ min) | 26 | $2,163 | $77 |
| Ultrasound of heart blood flow, valves and chambers | 131 | $2,149 | $16 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,777 | $105 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 14 | $1,717 | $123 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 26 | $1,602 | $62 |
| Heart muscle strain imaging | 33 | $1,445 | $39 |
| Heart rhythm recording of continous external ekg over 8-15 days | 98 | $1,310 | $12 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 47 | $1,044 | $21 |
| Evaluation of implantable heart and blood vessel monitoring system | 13 | $1,002 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 84 | $942 | $11 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 47 | $617 | $12 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 12 | $534 | $44 |
| Ultrasound of heart, follow-up | 20 | $497 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 135 | $388 | $3 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $287 | $19 |
| Ultrasonic guidance for blood vessel access | 15 | $185 | $12 |
2022: 46 services
| Long return visit (40+ min) | 476 | $146,399 | $162 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 384 | $81,239 | $187 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 51 | $78,898 | $1,547 |
| Ultrasound of both sides of head and neck blood flow | 321 | $63,136 | $194 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 51 | $42,098 | $417 |
| Return visit (30+ min) | 249 | $32,617 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $23,341 | $93 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 70 | $15,662 | $224 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 57 | $12,531 | $220 |
| Injection, regadenoson, 0.1 mg | 55 | $10,645 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $10,393 | $173 |
| Ultrasound of heart with probe in esophagus, with report | 100 | $10,010 | $97 |
| New patient visit (60+ min) | 45 | $8,471 | $188 |
| Programming of dual lead pacemaker system | 52 | $8,193 | $77 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $7,994 | $470 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 453 | $6,815 | $13 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 13 | $6,245 | $480 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $4,511 | $64 |
| New patient visit (45+ min) | 27 | $3,912 | $145 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 20 | $3,497 | $175 |
| 3d radiographic procedure | 124 | $3,109 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 45 | $2,961 | $66 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,629 | $97 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 15 | $2,585 | $172 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 13 | $2,267 | $87 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 89 | $2,259 | $24 |
| External shock to heart to regulate heart beat | 19 | $1,784 | $94 |
| Ultrasound of heart blood flow, valves and chambers | 102 | $1,715 | $16 |
| Short return visit (20+ min) | 18 | $1,559 | $82 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 67 | $1,556 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 38 | $1,494 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 90 | $1,389 | $14 |
| Anticoagulant management of patient taking warfarin | 12 | $1,323 | $10 |
| 3d radiographic procedure with computerized image postprocessing | 18 | $1,308 | $73 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 30 | $1,230 | $23 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 17 | $1,219 | $23 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 19 | $1,182 | $62 |
| Heart muscle strain imaging | 28 | $1,108 | $40 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 83 | $975 | $11 |
| Evaluation of implantable heart and blood vessel monitoring system | 12 | $973 | $46 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 35 | $771 | $21 |
| Injection for imaging of aorta above heart valve with review by radiologist | 12 | $533 | $44 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 34 | $503 | $14 |
| Ultrasound of heart, follow-up | 16 | $410 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 104 | $304 | $3 |
| Ultrasonic guidance for blood vessel access | 16 | $207 | $12 |
2021: 43 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 91 | $146,720 | $1,595 |
| Long return visit (40+ min) | 419 | $136,153 | $165 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 363 | $79,851 | $190 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 91 | $76,676 | $417 |
| Ultrasound of both sides of head and neck blood flow | 337 | $69,564 | $202 |
| Return visit (30+ min) | 300 | $43,186 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $19,195 | $93 |
| Injection, regadenoson, 0.1 mg | 98 | $19,190 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 56 | $12,282 | $219 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 51 | $11,265 | $221 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $10,845 | $181 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $9,103 | $455 |
| New patient visit (60+ min) | 39 | $8,082 | $207 |
| Programming of dual lead pacemaker system | 43 | $6,359 | $75 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 19 | $5,820 | $306 |
| Ultrasound of heart with probe in esophagus, with report | 57 | $5,714 | $99 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 86 | $5,676 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 70 | $4,870 | $64 |
| 3d radiographic procedure with computerized image postprocessing | 65 | $4,795 | $71 |
| Interpretation and report of ultrasound of heart | 49 | $4,047 | $81 |
| New patient visit (45+ min) | 27 | $3,951 | $146 |
| Anticoagulant management of patient taking warfarin | 15 | $3,857 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 209 | $3,757 | $13 |
| Telephone medical discussion with physician, 21-30 minutes | 31 | $3,290 | $87 |
| External shock to heart to regulate heart beat | 26 | $2,909 | $100 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,264 | $94 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 83 | $2,120 | $24 |
| Short return visit (20+ min) | 26 | $2,062 | $74 |
| Ultrasound of heart blood flow, valves and chambers | 100 | $1,750 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 31 | $1,715 | $25 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 23 | $1,515 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,465 | $49 |
| 3d radiographic procedure | 58 | $1,412 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 27 | $1,412 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 82 | $1,314 | $15 |
| Heart muscle strain imaging | 28 | $1,300 | $42 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,072 | $82 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 44 | $922 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 78 | $874 | $11 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 34 | $721 | $21 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 34 | $494 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 102 | $310 | $3 |
| Ultrasonic guidance for blood vessel access | 14 | $173 | $12 |
2020: 41 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 64 | $102,027 | $1,594 |
| Long return visit (40+ min) | 321 | $80,012 | $137 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 293 | $63,412 | $199 |
| Return visit (30+ min) | 378 | $54,111 | $94 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 64 | $52,757 | $412 |
| Ultrasound of both sides of head and neck blood flow | 239 | $46,901 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $22,006 | $96 |
| Injection, regadenoson, 0.1 mg | 66 | $12,214 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 54 | $11,358 | $210 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 491 | $11,250 | $15 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 49 | $11,009 | $220 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $10,007 | $185 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $8,859 | $443 |
| Interpretation and report of ultrasound of heart | 85 | $7,212 | $83 |
| New patient visit (60+ min) | 35 | $6,740 | $193 |
| Telephone medical discussion with physician, 11-20 minutes | 63 | $5,594 | $73 |
| Telephone medical discussion with physician, 21-30 minutes | 42 | $5,493 | $108 |
| New patient visit (45+ min) | 30 | $4,640 | $155 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 67 | $4,496 | $67 |
| Programming of dual lead pacemaker system | 40 | $4,430 | $66 |
| External ekg recording for more than 48 hours up to 21 days | 124 | $3,972 | $27 |
| Anticoagulant management of patient taking warfarin | 15 | $3,855 | $10 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 124 | $3,543 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $3,065 | $68 |
| Short return visit (20+ min) | 41 | $2,960 | $59 |
| External shock to heart to regulate heart beat | 14 | $1,851 | $103 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 106 | $1,735 | $6 |
| Ultrasound of heart blood flow, valves and chambers | 90 | $1,607 | $17 |
| 3d radiographic procedure | 62 | $1,505 | $23 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,405 | $100 |
| Return visit (30+ min) | 17 | $1,309 | $73 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $932 | $85 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $930 | $40 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $915 | $65 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 30 | $878 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 71 | $807 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 26 | $798 | $28 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $707 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $394 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 90 | $280 | $3 |
| Ultrasonic guidance for blood vessel access | 18 | $237 | $13 |
2019: 45 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 69 | $107,427 | $1,535 |
| Long return visit (40+ min) | 407 | $95,404 | $129 |
| Ultrasound of both sides of head and neck blood flow | 320 | $65,931 | $203 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 289 | $61,606 | $196 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 69 | $58,232 | $416 |
| Return visit (30+ min) | 355 | $47,191 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 656 | $18,332 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $18,319 | $93 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 65 | $14,586 | $221 |
| Injection, regadenoson, 0.1 mg | 74 | $13,729 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 62 | $13,598 | $219 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $12,571 | $483 |
| New patient visit (60+ min) | 51 | $8,855 | $174 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $7,111 | $182 |
| Programming of dual lead pacemaker system | 52 | $6,566 | $60 |
| Interpretation and report of ultrasound of heart | 78 | $6,550 | $81 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $6,037 | $503 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 80 | $5,540 | $68 |
| New patient visit (45+ min) | 35 | $4,974 | $142 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $4,618 | $330 |
| 3d radiographic procedure | 185 | $4,475 | $23 |
| Anticoagulant management of patient taking warfarin | 19 | $4,056 | $10 |
| External ekg recording for more than 48 hours up to 21 days | 117 | $3,459 | $27 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 19 | $3,352 | $168 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 49 | $3,318 | $66 |
| Short return visit (20+ min) | 47 | $3,197 | $58 |
| Ultrasound of heart blood flow, valves and chambers | 57 | $3,113 | $55 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 117 | $3,103 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,426 | $66 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $2,357 | $196 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 12 | $2,130 | $89 |
| External shock to heart to regulate heart beat | 16 | $1,838 | $97 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $1,812 | $151 |
| Evaluation of implantable heart and blood vessel monitoring system | 17 | $1,791 | $36 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 24 | $1,643 | $68 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 60 | $1,621 | $27 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $1,585 | $122 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 100 | $1,576 | $6 |
| Ultrasound of heart blood flow, valves and chambers | 85 | $1,467 | $17 |
| Programming of single lead pacemaker system | 11 | $1,390 | $50 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 102 | $1,213 | $11 |
| Return visit (30+ min) | 15 | $1,069 | $71 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $925 | $84 |
| Ultrasound of heart, follow-up | 14 | $422 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 85 | $256 | $3 |
2018: 49 services
| Long return visit (40+ min) | 436 | $102,913 | $125 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 60 | $91,965 | $1,508 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 288 | $62,483 | $198 |
| Ultrasound of both sides of head and neck blood flow | 288 | $60,885 | $205 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 60 | $47,974 | $396 |
| Return visit (30+ min) | 253 | $29,801 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $25,506 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 603 | $16,110 | $15 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $15,836 | $466 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 68 | $15,760 | $225 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 70 | $14,875 | $210 |
| Injection, regadenoson, 0.1 mg | 67 | $12,060 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $11,207 | $178 |
| New patient visit (60+ min) | 54 | $10,020 | $186 |
| Interpretation and report of ultrasound of heart | 117 | $9,651 | $80 |
| Programming of dual lead pacemaker system | 47 | $5,475 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 74 | $5,010 | $66 |
| Anticoagulant management of patient taking warfarin | 21 | $4,980 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 70 | $4,663 | $66 |
| 3d radiographic procedure | 175 | $4,324 | $23 |
| New patient visit (45+ min) | 32 | $4,029 | $126 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,884 | $324 |
| Ultrasound of heart blood flow, valves and chambers | 65 | $3,607 | $55 |
| Critical care, first 30-74 minutes | 11 | $3,106 | $194 |
| External ekg recording for more than 48 hours up to 21 days | 105 | $3,023 | $27 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 16 | $2,829 | $177 |
| External shock to heart to regulate heart beat | 25 | $2,760 | $99 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $2,746 | $229 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 106 | $2,716 | $24 |
| Short return visit (20+ min) | 39 | $2,664 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,523 | $65 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 27 | $2,459 | $82 |
| Ultrasound of heart blood flow, valves and chambers | 129 | $2,252 | $16 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 159 | $2,220 | $6 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $2,153 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 68 | $1,849 | $27 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $1,757 | $160 |
| Programming of dual lead implantable defibrillator system | 11 | $1,745 | $70 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,558 | $97 |
| Return visit (30+ min) | 19 | $1,398 | $70 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $1,311 | $82 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,073 | $98 |
| Programming of single lead pacemaker system | 12 | $1,066 | $44 |
| Evaluation of implantable heart and blood vessel monitoring system | 15 | $1,062 | $31 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 11 | $1,053 | $66 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 66 | $777 | $11 |
| Hospital observation care on day of discharge | 11 | $727 | $66 |
| Injection for imaging of aorta above heart valve with review by radiologist | 11 | $492 | $45 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 129 | $391 | $3 |
2017: 46 services
| Long return visit (40+ min) | 416 | $96,417 | $124 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 60 | $88,270 | $1,471 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 278 | $69,225 | $229 |
| Ultrasound of both sides of head and neck blood flow | 328 | $64,373 | $192 |
| Return visit (30+ min) | 306 | $33,863 | $88 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 60 | $27,536 | $229 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $22,227 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 562 | $15,781 | $15 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 55 | $14,724 | $268 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $14,429 | $180 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $13,964 | $423 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 66 | $13,420 | $197 |
| 3d radiographic procedure with computerized image postprocessing | 174 | $12,498 | $69 |
| Interpretation and report of ultrasound of heart | 143 | $11,810 | $80 |
| Injection, regadenoson, 0.1 mg | 62 | $10,760 | None |
| New patient visit (60+ min) | 47 | $7,922 | $169 |
| Programming of dual lead pacemaker system | 48 | $5,986 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 67 | $4,872 | $72 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 73 | $4,226 | $56 |
| Critical care, first 30-74 minutes | 13 | $3,710 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,608 | $64 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,574 | $298 |
| New patient visit (45+ min) | 21 | $3,077 | $147 |
| External ekg recording for more than 48 hours up to 21 days | 99 | $2,953 | $26 |
| Ultrasound of heart blood flow, valves and chambers | 53 | $2,910 | $55 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,901 | $264 |
| External shock to heart to regulate heart beat | 24 | $2,789 | $100 |
| Ultrasound of heart blood flow, valves and chambers | 161 | $2,716 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 99 | $2,635 | $24 |
| Short return visit (20+ min) | 35 | $2,390 | $60 |
| Programming of dual lead implantable defibrillator system | 11 | $2,379 | $74 |
| Hospital discharge day management, more than 30 minutes | 24 | $2,345 | $98 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 166 | $2,332 | $6 |
| 3d radiographic procedure | 77 | $1,900 | $23 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,792 | $94 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 20 | $1,717 | $82 |
| Return visit (30+ min) | 18 | $1,423 | $68 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 53 | $1,420 | $27 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 18 | $1,420 | $79 |
| Long return visit (40+ min) | 14 | $1,388 | $99 |
| Evaluation of implantable heart and blood vessel monitoring system | 19 | $1,121 | $27 |
| Injection for imaging of aorta above heart valve with review by radiologist | 20 | $898 | $45 |
| Limited ultrasound scan behind abdominal cavity | 12 | $690 | $58 |
| Short return visit (20+ min) | 13 | $590 | $45 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 161 | $472 | $3 |
| Ultrasound of heart, follow-up | 12 | $301 | $23 |
2016: 45 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 58 | $84,540 | $1,458 |
| Long return visit (40+ min) | 359 | $84,380 | $122 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 258 | $65,107 | $227 |
| Ultrasound of both sides of head and neck blood flow | 266 | $49,722 | $183 |
| Return visit (30+ min) | 263 | $29,883 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $26,420 | $91 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 58 | $26,275 | $227 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $14,849 | $177 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 62 | $14,181 | $225 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 498 | $13,313 | $15 |
| Interpretation and report of ultrasound of heart | 140 | $13,141 | $89 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 48 | $13,068 | $272 |
| 3d radiographic procedure with computerized image postprocessing | 160 | $11,786 | $68 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $10,891 | $474 |
| Injection, regadenoson, 0.1 mg | 61 | $10,315 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 116 | $6,618 | $56 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 18 | $5,772 | $321 |
| Programming of dual lead pacemaker system | 49 | $5,208 | $52 |
| Critical care, first 30-74 minutes | 21 | $5,174 | $192 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 66 | $4,731 | $72 |
| External shock to heart to regulate heart beat | 34 | $4,287 | $107 |
| New patient visit (60+ min) | 22 | $3,973 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $3,846 | $63 |
| New patient visit (45+ min) | 25 | $3,142 | $126 |
| Short return visit (20+ min) | 43 | $2,905 | $57 |
| External ekg recording for more than 48 hours up to 21 days | 92 | $2,693 | $27 |
| Ultrasound of heart blood flow, valves and chambers | 153 | $2,610 | $16 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 173 | $2,402 | $6 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 92 | $2,359 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 44 | $2,356 | $54 |
| 3d radiographic procedure | 93 | $2,165 | $22 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $2,106 | $162 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,815 | $96 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,386 | $107 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,356 | $65 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 16 | $1,289 | $81 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 13 | $1,261 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 44 | $1,147 | $26 |
| Return visit (30+ min) | 16 | $1,099 | $69 |
| Limited ultrasound scan behind abdominal cavity | 20 | $1,093 | $55 |
| Evaluation of implantable heart and blood vessel monitoring system | 17 | $953 | $26 |
| Hospital observation care on day of discharge | 11 | $711 | $65 |
| Injection for imaging of aorta above heart valve with review by radiologist | 15 | $657 | $44 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 152 | $452 | $3 |
| Ultrasound of heart, follow-up | 12 | $267 | $22 |
2015: 48 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 61 | $95,175 | $1,535 |
| Long return visit (40+ min) | 330 | $87,264 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 264 | $71,466 | $245 |
| Ultrasound of both sides of head and neck blood flow | 303 | $63,543 | $204 |
| Return visit (30+ min) | 330 | $49,151 | $103 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 61 | $29,366 | $241 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 115 | $28,335 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 531 | $16,689 | $17 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $15,200 | $190 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 45 | $13,375 | $291 |
| Interpretation and report of ultrasound of heart | 124 | $11,896 | $94 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $11,378 | $474 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $11,068 | $68 |
| Injection, regadenoson, 0.1 mg | 64 | $10,797 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 46 | $10,559 | $230 |
| Critical care, first 30-74 minutes | 26 | $9,883 | $206 |
| Programming of dual lead pacemaker system | 54 | $7,437 | $57 |
| 3d radiographic procedure with computerized image postprocessing | 96 | $6,339 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 102 | $6,305 | $60 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $5,650 | $353 |
| New patient visit (60+ min) | 28 | $5,593 | $200 |
| Short return visit (20+ min) | 67 | $5,153 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 67 | $5,096 | $75 |
| New patient visit (45+ min) | 22 | $3,274 | $149 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 183 | $3,231 | $7 |
| 3d radiographic procedure | 112 | $2,854 | $24 |
| External shock to heart to regulate heart beat | 23 | $2,816 | $117 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 28 | $2,809 | $97 |
| Ultrasound of heart blood flow, valves and chambers | 44 | $2,629 | $58 |
| Ultrasound of heart blood flow, valves and chambers | 139 | $2,479 | $17 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,366 | $103 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $2,267 | $174 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,958 | $89 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,881 | $70 |
| External ekg recording for more than 48 hours up to 21 days | 58 | $1,858 | $29 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,828 | $114 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 58 | $1,622 | $25 |
| Return visit (30+ min) | 19 | $1,548 | $74 |
| Programming of single lead pacemaker system | 14 | $1,365 | $49 |
| Limited ultrasound scan behind abdominal cavity | 21 | $1,312 | $60 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $1,310 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 44 | $1,294 | $29 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,222 | $87 |
| New patient visit (30+ min) | 11 | $1,174 | $107 |
| Injection for imaging of aorta above heart valve with review by radiologist | 21 | $984 | $47 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $960 | $28 |
| Short return visit | 11 | $519 | $40 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 139 | $449 | $3 |
2014: 45 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 86 | $130,357 | $1,481 |
| Long return visit (40+ min) | 266 | $65,925 | $128 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 246 | $62,570 | $230 |
| Ultrasound of both sides of head and neck blood flow | 311 | $57,785 | $182 |
| Return visit (30+ min) | 357 | $50,259 | $92 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 86 | $39,817 | $229 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $28,768 | $93 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 35 | $25,734 | $715 |
| Injection, regadenoson, 0.1 mg | 89 | $15,154 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 485 | $14,322 | $15 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 48 | $13,141 | $274 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $12,919 | $478 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 49 | $11,063 | $221 |
| 3d radiographic procedure with computerized image postprocessing | 117 | $10,703 | $82 |
| Critical care, first 30-74 minutes | 33 | $9,185 | $195 |
| Short return visit (20+ min) | 118 | $8,682 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 94 | $6,858 | $71 |
| Interpretation and report of ultrasound of heart | 119 | $6,623 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,121 | $180 |
| New patient visit (60+ min) | 32 | $5,971 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $5,257 | $64 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $4,744 | $339 |
| Programming of dual lead pacemaker system | 48 | $4,739 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $4,651 | $57 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 41 | $4,480 | $81 |
| New patient visit (45+ min) | 31 | $4,319 | $139 |
| Ultrasound of heart blood flow, valves and chambers | 47 | $2,560 | $54 |
| Ultrasound of heart blood flow, valves and chambers | 126 | $2,173 | $16 |
| Limited ultrasound scan behind abdominal cavity | 24 | $1,593 | $64 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 19 | $1,591 | $80 |
| External shock to heart to regulate heart beat | 14 | $1,567 | $104 |
| Return visit (30+ min) | 19 | $1,470 | $70 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,451 | $97 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 103 | $1,232 | $6 |
| Programming of single lead pacemaker system | 15 | $1,210 | $45 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $1,209 | $26 |
| Evaluation of implantable heart and blood vessel monitoring system | 20 | $1,196 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $1,145 | $35 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $1,114 | $80 |
| 3d radiographic procedure | 28 | $867 | $29 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 35 | $818 | $23 |
| Hospital discharge day management, 30 minutes or less | 11 | $788 | $66 |
| Injection for imaging of aorta above heart valve with review by radiologist | 18 | $781 | $43 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 126 | $393 | $3 |
| Ultrasound of heart, follow-up | 12 | $346 | $22 |
2013: 49 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 66 | $82,905 | $1,202 |
| Return visit (30+ min) | 357 | $58,517 | $93 |
| Ultrasound of both sides of head and neck blood flow | 295 | $56,992 | $188 |
| Long return visit (40+ min) | 253 | $56,775 | $125 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 258 | $52,686 | $182 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 40 | $34,437 | $783 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 66 | $31,472 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 135 | $26,040 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 454 | $14,902 | $17 |
| 3d radiographic procedure with computerized image postprocessing | 145 | $13,744 | $81 |
| Injection, regadenoson, 0.1 mg | 70 | $12,193 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $12,190 | $508 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 32 | $9,944 | $311 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 44 | $9,886 | $225 |
| Short return visit (20+ min) | 106 | $8,760 | $63 |
| Critical care, first 30-74 minutes | 24 | $7,441 | $191 |
| Ultrasound of heart with probe in esophagus, with report | 69 | $6,761 | $90 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $6,596 | $200 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $6,248 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 78 | $6,036 | $75 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $5,761 | $524 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | $5,641 | $54 |
| Programming of dual lead pacemaker system | 49 | $5,592 | $52 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 56 | $5,095 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,084 | $175 |
| Interpretation and report of ultrasound of heart | 88 | $4,779 | $51 |
| New patient visit (45+ min) | 24 | $3,396 | $142 |
| External shock to heart to regulate heart beat | 21 | $3,168 | $106 |
| Ultrasound of heart blood flow, valves and chambers | 148 | $2,655 | $16 |
| New patient visit (60+ min) | 13 | $2,424 | $186 |
| Limited ultrasound scan behind abdominal cavity | 18 | $2,259 | $113 |
| Ultrasound of heart blood flow, valves and chambers | 43 | $1,917 | $45 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 24 | $1,856 | $77 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $1,575 | $34 |
| Evaluation of implantable heart and blood vessel monitoring system | 17 | $1,477 | $26 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 18 | $1,466 | $77 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $1,374 | $60 |
| Return visit (30+ min) | 17 | $1,361 | $68 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 118 | $1,359 | $6 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,039 | $94 |
| Programming of single lead pacemaker system | 14 | $988 | $45 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 40 | $980 | $22 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 11 | $967 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 43 | $878 | $20 |
| Hospital discharge day management, 30 minutes or less | 12 | $770 | $64 |
| Injection for imaging of aorta above heart valve with review by radiologist | 17 | $717 | $42 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 11 | $707 | $17 |
| 3d radiographic procedure | 11 | $684 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 149 | $535 | $3 |
Drugs they prescribed that Part D paid
$1,324,341
Pharmacies billed $1,324,341 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 5,820) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
4,840 generic and 980 brand-name prescriptions · $1,324,341 in drug cost · 34 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 379 | $518,858 | $1,369 |
| Jardiance | 116 | $174,895 | $1,508 |
| Xarelto | 104 | $147,769 | $1,421 |
| Repatha Sureclick | 103 | $119,531 | $1,160 |
| Praluent | 95 | $103,183 | $1,086 |
See all 63 drugs
| Eliquis | 379 | $518,858 | $1,369 |
| Jardiance | 116 | $174,895 | $1,508 |
| Xarelto | 104 | $147,769 | $1,421 |
| Repatha Sureclick | 103 | $119,531 | $1,160 |
| Praluent | 95 | $103,183 | $1,086 |
| Entresto | 73 | $98,532 | $1,350 |
| Rosuvastatin | 591 | $10,859 | $18 |
| Metoprolol | 470 | $8,258 | $18 |
| Valsartan | 197 | $7,922 | $40 |
| Ezetimibe | 206 | $7,491 | $36 |
| Dofetilide | 25 | $6,568 | $263 |
| Atorvastatin | 456 | $6,001 | $13 |
| Eplerenone | 86 | $5,803 | $67 |
| Carvedilol Er | 12 | $4,518 | $376 |
| Amlodipine Besylate | 448 | $3,842 | $9 |
| Pravastatin | 176 | $3,693 | $21 |
| Losartan | 202 | $2,753 | $14 |
| Diltiazem 24hr Er (Cd) | 65 | $2,629 | $40 |
| Clopidogrel | 153 | $2,536 | $17 |
| Olmesartan Medoxomil | 79 | $2,479 | $31 |
| Propafenone Hcl Er | 13 | $2,433 | $187 |
| Carvedilol | 194 | $2,338 | $12 |
| Spironolactone | 180 | $2,116 | $12 |
| Potassium Chloride | 71 | $1,808 | $25 |
| Telmisartan | 37 | $1,783 | $48 |
| Candesartan Cilexetil | 13 | $1,500 | $115 |
| Lisinopril | 120 | $1,219 | $10 |
| Sotalol | 45 | $1,201 | $27 |
| Nebivolol | 13 | $1,167 | $90 |
| Irbesartan | 37 | $1,091 | $29 |
| Furosemide | 139 | $1,015 | $7 |
| Spironolactone-Hctz | 17 | $950 | $56 |
| Amlodipine-Valsartan | 12 | $901 | $75 |
| Nitroglycerin | 47 | $833 | $18 |
| Amiodarone | 29 | $831 | $29 |
| Pantoprazole | 30 | $739 | $25 |
| Olmesartan-Hydrochlorothiazide | 16 | $735 | $46 |
| Colchicine | 12 | $707 | $59 |
| Torsemide | 47 | $705 | $15 |
| Simvastatin | 39 | $595 | $15 |
| Hydrochlorothiazide | 94 | $592 | $6 |
| Nifedipine Er | 14 | $576 | $41 |
| Flecainide Acetate | 13 | $561 | $43 |
| Isosorbide Mononitrate Er | 13 | $510 | $39 |
| Propafenone | 12 | $508 | $42 |
| Valsartan-Hydrochlorothiazide | 15 | $499 | $33 |
| Losartan-Hydrochlorothiazide | 15 | $428 | $29 |
| Diltiazem 24hr Er | 11 | $428 | $39 |
| Sotalol Af | 11 | $281 | $26 |
| Triamterene-Hydrochlorothiazid | 32 | $280 | $9 |
| Tamsulosin | 13 | $268 | $21 |
| Levothyroxine | 16 | $238 | $15 |
| Benazepril | 20 | $235 | $12 |
| Warfarin | 22 | $225 | $10 |
| Verapamil Er | 12 | $207 | $17 |
| Hydralazine | 12 | $207 | $17 |
| Lovastatin | 11 | $139 | $13 |
| Lisinopril-Hydrochlorothiazide | 19 | $135 | $7 |
| Metoprolol | 37 | $135 | $4 |
| Omeprazole | 11 | $131 | $12 |
| Metformin | 16 | $70 | $4 |
| Amoxicillin | 21 | $60 | $3 |
| Clonidine | 11 | $39 | $4 |
Year by year
| 2024 | 5,820 | 730 | 0% (0) | 17% | $1,324,341 |
| 2023 | 5,553 | 686 | 0% (0) | None | $1,186,858 |
| 2022 | 4,829 | 619 | 0% (0) | None | $897,970 |
| 2021 | 5,001 | 567 | 0% (0) | 15% | $795,061 |
| 2020 | 4,897 | 540 | None | 16% | $661,858 |
| 2019 | 4,658 | 526 | 0% (0) | 16% | $595,796 |
| 2018 | 4,553 | 498 | 0% (0) | 18% | $561,136 |
| 2017 | 3,915 | 459 | 0% (0) | 22% | $466,208 |
| 2016 | 3,555 | 394 | 0% (0) | None | $412,079 |
| 2015 | 3,527 | 380 | None | 29% | $367,209 |
| 2014 | 3,738 | 356 | 0% (12) | 33% | $340,213 |
| 2013 | 3,789 | 353 | 1% (19) | 34% | $325,389 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 60 drugs
| Eliquis | 343 | $458,661 | $1,337 |
| Xarelto | 105 | $161,721 | $1,540 |
| Jardiance | 101 | $148,862 | $1,474 |
| Praluent | 102 | $112,927 | $1,107 |
| Repatha Sureclick | 71 | $69,212 | $975 |
| Entresto | 38 | $49,331 | $1,298 |
| Rosuvastatin | 493 | $17,458 | $35 |
| Dofetilide | 37 | $9,948 | $269 |
| Metoprolol | 453 | $8,606 | $19 |
| Valsartan | 154 | $8,060 | $52 |
| Atorvastatin | 468 | $7,433 | $16 |
| Carvedilol Er | 13 | $6,930 | $533 |
| Ezetimibe | 125 | $5,102 | $41 |
| Amlodipine Besylate | 475 | $4,626 | $10 |
| Olmesartan Medoxomil | 57 | $4,195 | $74 |
| Clopidogrel | 188 | $4,077 | $22 |
| Diltiazem 24hr Er (Cd) | 62 | $3,736 | $60 |
| Losartan | 233 | $3,279 | $14 |
| Pravastatin | 198 | $3,182 | $16 |
| Carvedilol | 185 | $3,027 | $16 |
| Potassium Chloride | 82 | $2,188 | $27 |
| Telmisartan | 35 | $2,164 | $62 |
| Eplerenone | 23 | $2,029 | $88 |
| Torsemide | 70 | $1,988 | $28 |
| Candesartan Cilexetil | 15 | $1,968 | $131 |
| Irbesartan | 32 | $1,831 | $57 |
| Nebivolol | 11 | $1,725 | $157 |
| Nitroglycerin | 56 | $1,538 | $27 |
| Toprol Xl | 15 | $1,518 | $101 |
| Spironolactone | 136 | $1,419 | $10 |
| Lisinopril | 107 | $1,254 | $12 |
| Flecainide Acetate | 18 | $1,149 | $64 |
| Furosemide | 140 | $997 | $7 |
| Amiodarone | 31 | $981 | $32 |
| Prasugrel | 14 | $964 | $69 |
| Propafenone | 12 | $924 | $77 |
| Pantoprazole | 41 | $862 | $21 |
| Valsartan-Hydrochlorothiazide | 12 | $812 | $68 |
| Simvastatin | 57 | $659 | $12 |
| Sotalol | 32 | $625 | $20 |
| Warfarin | 25 | $615 | $25 |
| Enalapril Maleate | 13 | $603 | $46 |
| Nifedipine Er | 15 | $600 | $40 |
| Spironolactone-Hctz | 19 | $553 | $29 |
| Diltiazem 24hr Er | 12 | $525 | $44 |
| Triamterene-Hydrochlorothiazid | 40 | $518 | $13 |
| Hydrochlorothiazide | 96 | $504 | $5 |
| Sotalol Af | 13 | $485 | $37 |
| Isosorbide Mononitrate Er | 11 | $439 | $40 |
| Hydralazine | 17 | $425 | $25 |
| Verapamil Er | 12 | $400 | $33 |
| Levothyroxine | 16 | $320 | $20 |
| Losartan-Hydrochlorothiazide | 11 | $298 | $27 |
| Chlorthalidone | 13 | $231 | $18 |
| Benazepril | 16 | $220 | $14 |
| Lovastatin | 11 | $183 | $17 |
| Metoprolol | 29 | $144 | $5 |
| Lisinopril-Hydrochlorothiazide | 23 | $115 | $5 |
| Amoxicillin | 25 | $94 | $4 |
| Metformin | 14 | $83 | $6 |
2022: 59 drugs
| Eliquis | 281 | $341,489 | $1,215 |
| Xarelto | 93 | $133,305 | $1,433 |
| Praluent | 92 | $95,518 | $1,038 |
| Jardiance | 50 | $60,041 | $1,201 |
| Repatha Sureclick | 55 | $48,884 | $889 |
| Entresto | 33 | $40,844 | $1,238 |
| Rosuvastatin | 426 | $21,540 | $51 |
| Multaq | 11 | $8,513 | $774 |
| Dofetilide | 20 | $8,372 | $419 |
| Metoprolol | 349 | $7,677 | $22 |
| Atorvastatin | 395 | $5,898 | $15 |
| Ezetimibe | 124 | $5,893 | $48 |
| Valsartan | 129 | $5,710 | $44 |
| Amlodipine Besylate | 396 | $4,336 | $11 |
| Pravastatin | 198 | $3,219 | $16 |
| Potassium Chloride | 92 | $3,090 | $34 |
| Losartan | 235 | $2,953 | $13 |
| Clopidogrel | 155 | $2,913 | $19 |
| Diltiazem 24hr Er (Cd) | 68 | $2,865 | $42 |
| Carvedilol | 159 | $2,821 | $18 |
| Irbesartan | 39 | $2,497 | $64 |
| Eplerenone | 19 | $2,251 | $118 |
| Olmesartan Medoxomil | 36 | $1,776 | $49 |
| Nebivolol | 25 | $1,644 | $66 |
| Toprol Xl | 16 | $1,635 | $102 |
| Telmisartan | 15 | $1,536 | $102 |
| Nitroglycerin | 58 | $1,473 | $25 |
| Torsemide | 55 | $1,465 | $27 |
| Prasugrel | 15 | $1,463 | $98 |
| Propafenone | 11 | $1,365 | $124 |
| Flecainide Acetate | 21 | $1,313 | $63 |
| Colchicine | 11 | $1,279 | $116 |
| Lisinopril | 91 | $1,035 | $11 |
| Verapamil Er | 15 | $1,004 | $67 |
| Spironolactone | 62 | $885 | $14 |
| Sotalol Af | 14 | $854 | $61 |
| Pantoprazole | 34 | $851 | $25 |
| Furosemide | 121 | $793 | $7 |
| Sotalol | 33 | $763 | $23 |
| Triamterene-Hydrochlorothiazid | 46 | $631 | $14 |
| Simvastatin | 60 | $560 | $9 |
| Warfarin | 28 | $537 | $19 |
| Isosorbide Mononitrate Er | 16 | $533 | $33 |
| Dilt-Xr | 11 | $512 | $47 |
| Hydrochlorothiazide | 84 | $510 | $6 |
| Amiodarone | 15 | $497 | $33 |
| Levothyroxine | 24 | $428 | $18 |
| Chlorthalidone | 12 | $414 | $35 |
| Valsartan-Hydrochlorothiazide | 11 | $397 | $36 |
| Metoprolol | 32 | $364 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $358 | $28 |
| Quinapril | 11 | $353 | $32 |
| Benazepril | 20 | $320 | $16 |
| Nifedipine Er | 14 | $272 | $19 |
| Diltiazem | 11 | $246 | $22 |
| Lovastatin | 13 | $206 | $16 |
| Amoxicillin | 15 | $53 | $4 |
| Metformin | 11 | $46 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $36 | $3 |
2021: 56 drugs
| Eliquis | 250 | $264,787 | $1,059 |
| Xarelto | 101 | $136,823 | $1,355 |
| Praluent | 89 | $77,593 | $872 |
| Repatha Sureclick | 52 | $41,347 | $795 |
| Entresto | 24 | $35,660 | $1,486 |
| Rosuvastatin | 422 | $21,210 | $50 |
| Dofetilide | 39 | $14,095 | $361 |
| Metoprolol | 402 | $8,721 | $22 |
| Bystolic | 21 | $8,552 | $407 |
| Atorvastatin | 383 | $7,140 | $19 |
| Repatha | 12 | $6,071 | $506 |
| Ezetimibe | 114 | $5,682 | $50 |
| Valsartan | 108 | $5,502 | $51 |
| Carvedilol Er | 14 | $5,467 | $390 |
| Diltiazem 24hr Er (Cd) | 87 | $4,532 | $52 |
| Pravastatin | 223 | $4,358 | $20 |
| Potassium Chloride | 83 | $4,085 | $49 |
| Amlodipine Besylate | 383 | $4,081 | $11 |
| Clopidogrel | 195 | $4,026 | $21 |
| Losartan | 224 | $3,700 | $17 |
| Eplerenone | 28 | $3,111 | $111 |
| Irbesartan | 47 | $3,088 | $66 |
| Carvedilol | 189 | $2,597 | $14 |
| Flecainide Acetate | 25 | $2,571 | $103 |
| Propafenone | 15 | $2,516 | $168 |
| Prasugrel | 28 | $2,085 | $74 |
| Torsemide | 64 | $1,973 | $31 |
| Sotalol Af | 20 | $1,588 | $79 |
| Valsartan-Hydrochlorothiazide | 25 | $1,577 | $63 |
| Lisinopril | 144 | $1,485 | $10 |
| Telmisartan | 14 | $1,456 | $104 |
| Olmesartan Medoxomil | 37 | $1,449 | $39 |
| Olmesartan-Hydrochlorothiazide | 12 | $1,427 | $119 |
| Toprol Xl | 12 | $1,155 | $96 |
| Nitroglycerin | 55 | $1,107 | $20 |
| Colchicine | 11 | $1,027 | $93 |
| Sotalol | 42 | $952 | $23 |
| Furosemide | 128 | $927 | $7 |
| Warfarin | 50 | $909 | $18 |
| Isosorbide Mononitrate Er | 14 | $638 | $46 |
| Pantoprazole | 29 | $634 | $22 |
| Triamterene-Hydrochlorothiazid | 41 | $625 | $15 |
| Simvastatin | 57 | $613 | $11 |
| Spironolactone | 58 | $606 | $10 |
| Dilt-Xr | 11 | $595 | $54 |
| Hydrochlorothiazide | 83 | $504 | $6 |
| Quinapril | 17 | $448 | $26 |
| Hydralazine | 24 | $404 | $17 |
| Losartan-Hydrochlorothiazide | 14 | $402 | $29 |
| Metoprolol | 35 | $386 | $11 |
| Amiodarone | 14 | $366 | $26 |
| Levothyroxine | 22 | $344 | $16 |
| Clonidine | 21 | $288 | $14 |
| Lovastatin | 22 | $198 | $9 |
| Benazepril | 22 | $196 | $9 |
| Lisinopril-Hydrochlorothiazide | 12 | $122 | $10 |
2020: 55 drugs
| Eliquis | 232 | $196,881 | $849 |
| Xarelto | 144 | $153,958 | $1,069 |
| Praluent | 70 | $42,987 | $614 |
| Rosuvastatin | 386 | $25,603 | $66 |
| Repatha Sureclick | 30 | $19,720 | $657 |
| Dofetilide | 38 | $13,086 | $344 |
| Pradaxa | 11 | $12,783 | $1,162 |
| Metoprolol | 475 | $11,382 | $24 |
| Bystolic | 26 | $11,318 | $435 |
| Brilinta | 12 | $10,369 | $864 |
| Atorvastatin | 383 | $7,739 | $20 |
| Ezetimibe | 120 | $7,278 | $61 |
| Repatha | 13 | $6,242 | $480 |
| Pravastatin | 220 | $5,483 | $25 |
| Carvedilol Er | 12 | $5,212 | $434 |
| Flecainide Acetate | 36 | $4,762 | $132 |
| Valsartan | 75 | $4,306 | $57 |
| Clopidogrel | 195 | $4,199 | $22 |
| Diltiazem 24hr Er (Cd) | 96 | $3,977 | $41 |
| Potassium Chloride | 110 | $3,705 | $34 |
| Amlodipine Besylate | 370 | $3,638 | $10 |
| Losartan | 240 | $3,536 | $15 |
| Eplerenone | 27 | $3,110 | $115 |
| Micardis | 13 | $2,740 | $211 |
| Irbesartan | 69 | $2,519 | $37 |
| Carvedilol | 152 | $2,148 | $14 |
| Telmisartan | 17 | $2,103 | $124 |
| Olmesartan Medoxomil | 40 | $2,018 | $50 |
| Amiodarone | 15 | $1,642 | $109 |
| Sotalol Af | 19 | $1,618 | $85 |
| Torsemide | 66 | $1,527 | $23 |
| Valsartan-Hydrochlorothiazide | 19 | $1,358 | $71 |
| Lisinopril | 107 | $1,305 | $12 |
| Nitroglycerin | 44 | $1,144 | $26 |
| Losartan-Hydrochlorothiazide | 13 | $961 | $74 |
| Sotalol | 42 | $921 | $22 |
| Furosemide | 133 | $774 | $6 |
| Pantoprazole | 27 | $693 | $26 |
| Prasugrel | 21 | $670 | $32 |
| Warfarin | 42 | $625 | $15 |
| Simvastatin | 67 | $620 | $9 |
| Hydrochlorothiazide | 84 | $541 | $6 |
| Cartia Xt | 22 | $516 | $23 |
| Metoprolol | 32 | $494 | $15 |
| Spironolactone | 36 | $366 | $10 |
| Triamterene-Hydrochlorothiazid | 24 | $358 | $15 |
| Enalapril Maleate | 14 | $337 | $24 |
| Quinapril | 12 | $322 | $27 |
| Tamsulosin | 12 | $318 | $27 |
| Lovastatin | 16 | $299 | $19 |
| Klor-Con 10 | 11 | $252 | $23 |
| Hydralazine | 17 | $211 | $12 |
| Benazepril | 17 | $157 | $9 |
| Clonidine | 17 | $108 | $6 |
| Allopurinol | 15 | $107 | $7 |
2019: 53 drugs
| Eliquis | 225 | $173,517 | $771 |
| Xarelto | 148 | $131,005 | $885 |
| Praluent | 54 | $48,149 | $892 |
| Rosuvastatin | 314 | $23,840 | $76 |
| Dofetilide | 42 | $18,507 | $441 |
| Repatha | 13 | $13,383 | $1,029 |
| Metoprolol | 460 | $13,362 | $29 |
| Repatha Sureclick | 15 | $13,243 | $883 |
| Atorvastatin | 318 | $6,984 | $22 |
| Bystolic | 19 | $6,970 | $367 |
| Pravastatin | 213 | $5,781 | $27 |
| Propafenone Hcl Er | 15 | $4,707 | $314 |
| Eplerenone | 18 | $4,702 | $261 |
| Amlodipine Besylate | 405 | $3,964 | $10 |
| Clopidogrel | 190 | $3,926 | $21 |
| Ezetimibe | 53 | $3,715 | $70 |
| Valsartan | 76 | $3,604 | $47 |
| Flecainide Acetate | 36 | $3,487 | $97 |
| Diltiazem 24hr Er (Cd) | 65 | $3,251 | $50 |
| Micardis | 14 | $2,961 | $212 |
| Losartan | 222 | $2,499 | $11 |
| Olmesartan Medoxomil | 51 | $2,366 | $46 |
| Telmisartan | 17 | $2,309 | $136 |
| Carvedilol | 168 | $2,250 | $13 |
| Potassium Chloride | 72 | $2,232 | $31 |
| Irbesartan | 73 | $2,189 | $30 |
| Amiodarone | 24 | $1,767 | $74 |
| Candesartan Cilexetil | 11 | $1,605 | $146 |
| Dilt-Xr | 15 | $1,347 | $90 |
| Torsemide | 50 | $1,294 | $26 |
| Nitroglycerin | 66 | $1,262 | $19 |
| Valsartan-Hydrochlorothiazide | 23 | $1,151 | $50 |
| Lisinopril | 105 | $1,123 | $11 |
| Toprol Xl | 19 | $1,100 | $58 |
| Cartia Xt | 21 | $1,076 | $51 |
| Sotalol Af | 15 | $1,054 | $70 |
| Olmesartan-Hydrochlorothiazide | 12 | $1,000 | $83 |
| Furosemide | 161 | $945 | $6 |
| Warfarin | 43 | $875 | $20 |
| Amlodipine-Valsartan | 20 | $786 | $39 |
| Hydrochlorothiazide | 110 | $685 | $6 |
| Simvastatin | 84 | $682 | $8 |
| Sotalol | 32 | $668 | $21 |
| Spironolactone | 58 | $577 | $10 |
| Triamterene-Hydrochlorothiazid | 23 | $397 | $17 |
| Benazepril | 27 | $396 | $15 |
| Quinapril | 12 | $378 | $32 |
| Pantoprazole | 28 | $356 | $13 |
| Metoprolol | 43 | $336 | $8 |
| Losartan-Hydrochlorothiazide | 15 | $256 | $17 |
| Clonidine | 19 | $228 | $12 |
| Ramipril | 13 | $181 | $14 |
| Hydralazine | 14 | $172 | $12 |
2018: 55 drugs
| Eliquis | 227 | $159,108 | $701 |
| Xarelto | 114 | $101,483 | $890 |
| Praluent | 40 | $57,407 | $1,435 |
| Rosuvastatin | 269 | $17,661 | $66 |
| Repatha | 14 | $16,434 | $1,174 |
| Metoprolol | 444 | $15,986 | $36 |
| Dofetilide | 36 | $14,454 | $402 |
| Repatha Sureclick | 13 | $14,379 | $1,106 |
| Entresto | 15 | $10,938 | $729 |
| Bystolic | 48 | $10,747 | $224 |
| Atorvastatin | 311 | $6,881 | $22 |
| Pravastatin | 194 | $5,942 | $31 |
| Eplerenone | 22 | $4,788 | $218 |
| Valsartan | 104 | $3,945 | $38 |
| Clopidogrel | 176 | $3,671 | $21 |
| Amlodipine Besylate | 392 | $3,636 | $9 |
| Micardis | 14 | $3,107 | $222 |
| Olmesartan Medoxomil | 41 | $2,818 | $69 |
| Flecainide Acetate | 42 | $2,771 | $66 |
| Cartia Xt | 55 | $2,411 | $44 |
| Amiodarone | 27 | $2,275 | $84 |
| Losartan | 198 | $2,037 | $10 |
| Diltiazem 24hr Er (Cd) | 53 | $1,965 | $37 |
| Sotalol Af | 12 | $1,919 | $160 |
| Ezetimibe | 19 | $1,874 | $99 |
| Irbesartan | 70 | $1,767 | $25 |
| Potassium Chloride | 46 | $1,746 | $38 |
| Carvedilol | 142 | $1,650 | $12 |
| Valsartan-Hydrochlorothiazide | 21 | $1,343 | $64 |
| Torsemide | 70 | $1,305 | $19 |
| Nitroglycerin | 62 | $1,144 | $18 |
| Warfarin | 48 | $1,122 | $23 |
| Lisinopril | 127 | $1,053 | $8 |
| Toprol Xl | 11 | $1,048 | $95 |
| Furosemide | 188 | $918 | $5 |
| Propafenone Hcl Er | 12 | $905 | $75 |
| Simvastatin | 88 | $826 | $9 |
| Candesartan Cilexetil | 13 | $716 | $55 |
| Spironolactone | 86 | $693 | $8 |
| Amlodipine-Valsartan | 15 | $682 | $45 |
| Verapamil Er | 13 | $552 | $42 |
| Metoprolol | 76 | $477 | $6 |
| Hydrochlorothiazide | 61 | $472 | $8 |
| Levothyroxine | 23 | $437 | $19 |
| Benazepril | 25 | $324 | $13 |
| Isosorbide Mononitrate Er | 11 | $319 | $29 |
| Klor-Con 10 | 12 | $316 | $26 |
| Pantoprazole | 32 | $306 | $10 |
| Triamterene-Hydrochlorothiazid | 22 | $292 | $13 |
| Sotalol | 11 | $252 | $23 |
| Omeprazole | 12 | $238 | $20 |
| Losartan-Hydrochlorothiazide | 18 | $202 | $11 |
| Lovastatin | 14 | $191 | $14 |
| Ramipril | 11 | $150 | $14 |
| Famotidine | 18 | $147 | $8 |
2017: 50 drugs
| Eliquis | 145 | $100,320 | $692 |
| Xarelto | 84 | $69,754 | $830 |
| Dofetilide | 32 | $24,238 | $757 |
| Effient | 20 | $23,718 | $1,186 |
| Rosuvastatin | 220 | $17,668 | $80 |
| Repatha | 13 | $15,688 | $1,207 |
| Brilinta | 26 | $14,679 | $565 |
| Metoprolol | 379 | $12,722 | $34 |
| Bystolic | 52 | $10,853 | $209 |
| Benicar | 15 | $7,429 | $495 |
| Tikosyn | 12 | $6,541 | $545 |
| Crestor | 17 | $6,016 | $354 |
| Atorvastatin | 269 | $5,765 | $21 |
| Eplerenone | 17 | $4,790 | $282 |
| Pravastatin | 181 | $4,586 | $25 |
| Amlodipine Besylate | 338 | $2,999 | $9 |
| Lipitor | 11 | $2,902 | $264 |
| Valsartan | 74 | $2,829 | $38 |
| Flecainide Acetate | 21 | $2,827 | $135 |
| Clopidogrel | 126 | $2,644 | $21 |
| Amiodarone | 14 | $2,364 | $169 |
| Micardis | 12 | $2,252 | $188 |
| Losartan | 189 | $1,707 | $9 |
| Warfarin | 95 | $1,684 | $18 |
| Nitroglycerin | 64 | $1,614 | $25 |
| Valsartan-Hydrochlorothiazide | 22 | $1,424 | $65 |
| Diltiazem 24hr Er | 62 | $1,412 | $23 |
| Potassium Chloride | 37 | $1,361 | $37 |
| Lisinopril | 150 | $1,120 | $7 |
| Cartia Xt | 40 | $1,115 | $28 |
| Sotalol Af | 12 | $1,063 | $89 |
| Toprol Xl | 16 | $1,034 | $65 |
| Carvedilol | 103 | $950 | $9 |
| Furosemide | 166 | $933 | $6 |
| Simvastatin | 76 | $785 | $10 |
| Spironolactone | 77 | $782 | $10 |
| Amlodipine-Valsartan | 12 | $706 | $59 |
| Metoprolol | 73 | $594 | $8 |
| Torsemide | 43 | $528 | $12 |
| Isosorbide Mononitrate Er | 20 | $435 | $22 |
| Levothyroxine | 14 | $404 | $29 |
| Hydrochlorothiazide | 42 | $390 | $9 |
| Sotalol | 14 | $298 | $21 |
| Benazepril | 23 | $281 | $12 |
| Omeprazole | 13 | $280 | $22 |
| Pantoprazole | 29 | $237 | $8 |
| Losartan-Hydrochlorothiazide | 12 | $211 | $18 |
| Triamterene-Hydrochlorothiazid | 11 | $152 | $14 |
| Hydralazine | 13 | $149 | $11 |
| Famotidine | 23 | $64 | $3 |
2016: 51 drugs
| Eliquis | 139 | $75,888 | $546 |
| Xarelto | 83 | $61,619 | $742 |
| Crestor | 101 | $51,311 | $508 |
| Tikosyn | 26 | $21,307 | $820 |
| Effient | 17 | $15,151 | $891 |
| Multaq | 17 | $12,413 | $730 |
| Metoprolol | 349 | $11,562 | $33 |
| Benicar | 19 | $9,845 | $518 |
| Bystolic | 32 | $8,646 | $270 |
| Rosuvastatin | 63 | $8,641 | $137 |
| Brilinta | 16 | $7,960 | $497 |
| Pradaxa | 11 | $7,311 | $665 |
| Atorvastatin | 221 | $5,991 | $27 |
| Eplerenone | 28 | $5,749 | $205 |
| Valsartan | 81 | $4,987 | $62 |
| Pravastatin | 139 | $4,474 | $32 |
| Aspirin-Dipyridamole Er | 12 | $3,774 | $315 |
| Lipitor | 13 | $2,876 | $221 |
| Amiodarone | 22 | $2,855 | $130 |
| Micardis | 15 | $2,680 | $179 |
| Amlodipine Besylate | 286 | $2,531 | $9 |
| Clopidogrel | 119 | $2,325 | $20 |
| Potassium Chloride | 39 | $1,939 | $50 |
| Warfarin | 100 | $1,834 | $18 |
| Losartan | 155 | $1,624 | $10 |
| Diltiazem 24hr Er | 42 | $1,606 | $38 |
| Carvedilol | 139 | $1,402 | $10 |
| Nitrostat | 42 | $1,329 | $32 |
| Lisinopril | 158 | $1,099 | $7 |
| Klor-Con 10 | 19 | $1,058 | $56 |
| Torsemide | 50 | $1,017 | $20 |
| Propafenone | 16 | $1,016 | $64 |
| Valsartan-Hydrochlorothiazide | 13 | $1,011 | $78 |
| Furosemide | 166 | $911 | $5 |
| Spironolactone | 90 | $861 | $10 |
| Simvastatin | 88 | $803 | $9 |
| Toprol Xl | 17 | $642 | $38 |
| Cartia Xt | 18 | $581 | $32 |
| Levothyroxine | 33 | $566 | $17 |
| Metoprolol | 65 | $494 | $8 |
| Isosorbide Mononitrate Er | 17 | $436 | $26 |
| Omeprazole | 15 | $359 | $24 |
| Nitroglycerin | 11 | $352 | $32 |
| Sotalol | 20 | $295 | $15 |
| Verapamil Er | 15 | $293 | $20 |
| Triamterene-Hydrochlorothiazid | 16 | $282 | $18 |
| Pantoprazole | 17 | $281 | $17 |
| Benazepril | 30 | $272 | $9 |
| Hydrochlorothiazide | 24 | $186 | $8 |
| Losartan-Hydrochlorothiazide | 12 | $163 | $14 |
| Atenolol | 11 | $81 | $7 |
2015: 47 drugs
| Eliquis | 119 | $58,000 | $487 |
| Crestor | 130 | $57,527 | $443 |
| Xarelto | 114 | $57,295 | $503 |
| Tikosyn | 45 | $24,259 | $539 |
| Effient | 27 | $17,299 | $641 |
| Metoprolol | 303 | $11,033 | $36 |
| Valsartan | 95 | $9,796 | $103 |
| Bystolic | 54 | $9,313 | $172 |
| Pradaxa | 17 | $6,967 | $410 |
| Benicar | 18 | $6,276 | $349 |
| Atorvastatin | 207 | $5,896 | $28 |
| Eplerenone | 33 | $5,488 | $166 |
| Pravastatin | 133 | $4,598 | $35 |
| Coreg Cr | 12 | $3,970 | $331 |
| Exforge | 13 | $3,895 | $300 |
| Fenofibrate | 22 | $2,818 | $128 |
| Clopidogrel | 128 | $2,648 | $21 |
| Potassium Chloride | 82 | $2,188 | $27 |
| Losartan | 154 | $2,030 | $13 |
| Warfarin | 96 | $1,853 | $19 |
| Amlodipine Besylate | 244 | $1,596 | $7 |
| Diltiazem Er | 17 | $1,412 | $83 |
| Carvedilol | 144 | $1,383 | $10 |
| Candesartan Cilexetil | 14 | $1,250 | $89 |
| Diltiazem 24hr Er | 45 | $1,236 | $27 |
| Valsartan-Hydrochlorothiazide | 20 | $1,191 | $60 |
| Torsemide | 69 | $1,057 | $15 |
| Amiodarone | 26 | $979 | $38 |
| Diltiazem 24hr Cd | 16 | $953 | $60 |
| Omeprazole | 27 | $927 | $34 |
| Lisinopril | 133 | $883 | $7 |
| Furosemide | 152 | $860 | $6 |
| Simvastatin | 113 | $741 | $7 |
| Nitrostat | 33 | $578 | $18 |
| Metoprolol | 72 | $466 | $6 |
| Verapamil Er | 14 | $448 | $32 |
| Spironolactone | 57 | $435 | $8 |
| Toprol Xl | 12 | $426 | $36 |
| Allopurinol | 13 | $384 | $30 |
| Levothyroxine | 16 | $379 | $24 |
| Sotalol Af | 12 | $299 | $25 |
| Sotalol | 21 | $253 | $12 |
| Pantoprazole | 16 | $243 | $15 |
| Lovastatin | 12 | $164 | $14 |
| Atenolol | 30 | $151 | $5 |
| Triamterene-Hydrochlorothiazid | 18 | $151 | $8 |
| Hydrochlorothiazide | 17 | $129 | $8 |
2014: 57 drugs
| Xarelto | 126 | $50,207 | $398 |
| Crestor | 148 | $46,577 | $315 |
| Eliquis | 104 | $38,458 | $370 |
| Tikosyn | 68 | $24,938 | $367 |
| Diovan | 66 | $20,809 | $315 |
| Pradaxa | 33 | $11,563 | $350 |
| Bystolic | 87 | $10,124 | $116 |
| Metoprolol | 267 | $9,937 | $37 |
| Exforge | 30 | $7,940 | $265 |
| Valsartan | 27 | $6,515 | $241 |
| Atorvastatin | 244 | $6,230 | $26 |
| Benicar | 16 | $6,153 | $385 |
| Azor | 12 | $5,063 | $422 |
| Clopidogrel | 122 | $4,691 | $38 |
| Pravastatin | 147 | $3,946 | $27 |
| Benicar Hct | 11 | $3,670 | $334 |
| Eplerenone | 15 | $2,887 | $192 |
| Fenofibrate | 16 | $2,697 | $169 |
| Diltiazem Er | 45 | $2,500 | $56 |
| Amlodipine Besylate | 288 | $2,329 | $8 |
| Carvedilol | 185 | $2,100 | $11 |
| Losartan | 150 | $1,780 | $12 |
| Tekturna Hct | 12 | $1,761 | $147 |
| Diltiazem 24hr Er | 58 | $1,718 | $30 |
| Warfarin | 96 | $1,681 | $18 |
| Potassium Chloride | 52 | $1,429 | $27 |
| Simvastatin | 110 | $1,070 | $10 |
| Lisinopril | 133 | $1,032 | $8 |
| Amlodipine Besylate-Benazepril | 12 | $991 | $83 |
| Torsemide | 53 | $920 | $17 |
| Telmisartan | 11 | $857 | $78 |
| Spironolactone | 82 | $773 | $9 |
| Toprol Xl | 11 | $733 | $67 |
| Diltiazem 24hr Cd | 22 | $698 | $32 |
| Furosemide | 134 | $692 | $5 |
| Propafenone | 11 | $460 | $42 |
| Sotalol | 31 | $459 | $15 |
| Nitrostat | 36 | $458 | $13 |
| Quinapril | 12 | $424 | $35 |
| Verapamil Er | 15 | $411 | $27 |
| Klor-Con 10 | 11 | $406 | $37 |
| Isosorbide Mononitrate Er | 19 | $389 | $20 |
| Ramipril | 13 | $371 | $29 |
| Metoprolol | 54 | $364 | $7 |
| Digoxin | 15 | $357 | $24 |
| Allopurinol | 27 | $280 | $10 |
| Pantoprazole | 24 | $278 | $12 |
| Omeprazole | 19 | $264 | $14 |
| Levothyroxine | 11 | $258 | $23 |
| Amiodarone | 12 | $228 | $19 |
| Triamterene-Hydrochlorothiazid | 17 | $226 | $13 |
| Benazepril | 18 | $224 | $12 |
| Lisinopril-Hydrochlorothiazide | 14 | $218 | $16 |
| Hydrochlorothiazide | 19 | $205 | $11 |
| Atenolol | 26 | $169 | $7 |
| Losartan-Hydrochlorothiazide | 11 | $168 | $15 |
| Zolpidem | 14 | $56 | $4 |
2013: 57 drugs
| Xarelto | 158 | $54,063 | $342 |
| Crestor | 148 | $44,055 | $298 |
| Diovan | 135 | $33,592 | $249 |
| Pradaxa | 63 | $23,012 | $365 |
| Tikosyn | 70 | $20,142 | $288 |
| Eliquis | 35 | $9,486 | $271 |
| Metoprolol | 247 | $9,236 | $37 |
| Exforge | 37 | $8,600 | $232 |
| Atorvastatin | 196 | $8,197 | $42 |
| Bystolic | 80 | $7,939 | $99 |
| Propafenone | 27 | $7,269 | $269 |
| Clopidogrel | 110 | $3,977 | $36 |
| Amlodipine Besylate | 291 | $2,828 | $10 |
| Fenofibrate | 13 | $2,560 | $197 |
| Carvedilol | 157 | $2,421 | $15 |
| Coreg Cr | 11 | $2,215 | $201 |
| Diltiazem Er | 28 | $1,916 | $68 |
| Losartan | 143 | $1,913 | $13 |
| Pravastatin | 106 | $1,911 | $18 |
| Toprol Xl | 23 | $1,900 | $83 |
| Atacand | 12 | $1,875 | $156 |
| Torsemide | 66 | $1,858 | $28 |
| Eplerenone | 12 | $1,539 | $128 |
| Warfarin | 82 | $1,509 | $18 |
| Simvastatin | 142 | $1,464 | $10 |
| Tekturna Hct | 11 | $1,450 | $132 |
| Diltiazem 24hr Er | 44 | $1,186 | $27 |
| Lisinopril | 157 | $1,172 | $7 |
| Potassium Chloride | 34 | $984 | $29 |
| Spironolactone | 86 | $856 | $10 |
| Amlodipine Besylate-Benazepril | 12 | $764 | $64 |
| Diltiazem 24hr Cd | 29 | $719 | $25 |
| Isosorbide Mononitrate Er | 33 | $647 | $20 |
| Nifedipine Er | 13 | $510 | $39 |
| Furosemide | 111 | $506 | $5 |
| Losartan-Hydrochlorothiazide | 26 | $469 | $18 |
| Metoprolol | 56 | $464 | $8 |
| Nitrostat | 29 | $455 | $16 |
| Pantoprazole | 41 | $426 | $10 |
| Verapamil Er | 11 | $372 | $34 |
| Felodipine Er | 14 | $368 | $26 |
| Sotalol | 24 | $355 | $15 |
| Benazepril | 24 | $340 | $14 |
| Digox | 37 | $314 | $8 |
| Levothyroxine | 19 | $314 | $17 |
| Quinapril | 18 | $313 | $17 |
| Allopurinol | 37 | $303 | $8 |
| Ramipril | 17 | $263 | $15 |
| Amiodarone | 19 | $258 | $14 |
| Omeprazole | 19 | $209 | $11 |
| Hydrochlorothiazide | 23 | $206 | $9 |
| Atenolol | 23 | $192 | $8 |
| Sotalol Af | 17 | $185 | $11 |
| Triamterene-Hctz | 12 | $173 | $14 |
| Klor-Con M10 | 12 | $141 | $12 |
| Lovastatin | 13 | $139 | $11 |
| Hydrocodone-Acetaminophen | 11 | $79 | $7 |
Money from drug and device companies
$199 in 2025
| 2025 | 3 | 3 | None | $199 |
| 2024 | 1 | 1 | None | $26 |
| 2023 | 1 | 1 | None | $18 |
| 2022 | 2 | 2 | None | $240 |
| 2021 | 1 | 1 | None | $28 |
| 2020 | 1 | 1 | None | $24 |
| 2019 | 2 | 5 | None | $120 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Aurora Ev-Icd Mri Surescan | $164 | 1 payment
|
| Abbott Laboratories | Xience Skypoint | $21 | 1 payment
|
| Scpharmaceuticals | Furoscix | $15 | 1 payment
|
See all 3 published payments
| Abbott Laboratories | Meals · 2025-11-11 | Xience Skypoint | $21 |
| Scpharmaceuticals | Meals · 2025-06-19 | Furoscix | $15 |
| Medtronic | Meals · 2025-05-19 | Aurora Ev-Icd Mri Surescan | $164 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $26
| Medtronic | Onyx Frontier | $26 | 1 payment
|
2023: $18
| Scpharmaceuticals | Furoscix | $18 | 1 payment
|
2022: $240
| Impulse Dynamics (USA) | Optimizer | $217 | 1 payment
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $23 | 1 payment
|
2021: $28
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $28 | 1 payment
|
2020: $24
| Abiomed | Impella | $24 | 1 payment
|
2019: $120
| Novartis Pharmaceuticals | Entresto | $89 | 4 payments
|
| Amgen | Corlanor | $31 | 1 payment
|
Professional record
- NPI
- 1790719268
- Licence
- CA G68721California G68721: Current · expires 2027-11-30
- Trained
- Hahnemann University College of Medicine, 1988
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-10
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.